Another Indian COVID-19 vaccine candidate will start human trials soon

Dr VK Paul, Member of NITI Aayog, on Tuesday said the Drugs Controller General of India (DCGI) had recently granted clearance for an additional Covid-19 vaccine candidate from Gennova Pharmaceuticals Ltd. Gennova, in association with the Department of Biotechnology, a research agency under the government of India, has developed the vaccine. The technology used to develop this vaccine is same as the one used for the Pfizer vaccine, said Paul.

The company had on Friday received approval from the Drug Controller General of India for conducting a phase 1 and 2 clinical trial for safety and immunogenicity.

However, the storage procedure for this vaccine would not be the same as followed for the Pfizer vaccine or any other vaccine that has been developed so far. If it comes into existence, it will be maintained at normal cold chain conditions, in a normal fridge, said the NITI Aayog member.

There are eight vaccines that are currently at different stages of development in the country.

Source: https://www.livemint.com/news/india/india-gives-nod-to-conduct-trials-of-gennova-s-covid-19-vaccine-11608031317794.html